These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2169975)

  • 1. [Thrombopenia induced by a low molecular weight heparin].
    Wattrisse G; Lecoutre D; Groux-Pante C
    Cah Anesthesiol; 1990; 38(3):175-7. PubMed ID: 2169975
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombopenia caused by low molecular weight heparin].
    Tardy B; Page Y; Tardy-Poncet B; Comtet C; Zeni F; Bertrand JC
    Therapie; 1990; 45(5):453. PubMed ID: 2175456
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombopenia under low molecular weight heparin after treatment with pentosan polyphosphate].
    Paille F; Boccaccini A; de Korwin JD; Schmidt C; Laprevote MC; Schmitt J; Royer RJ
    Therapie; 1988; 43(4):322-3. PubMed ID: 2460963
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin induced thrombocytopenia after low molecular weight heparin treatment: a case report.
    Illuminati G; Caliò FG; Bertagni A; Forte A; Gallinaro L; Montesano G; Ciulli A
    Riv Eur Sci Med Farmacol; 1996; 18(5-6):225-8. PubMed ID: 9177626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombocytopenia induced by low molecular weight heparin].
    Ríos Herranz E; Briz Blanco M; Cabrera Marín JR; Fernández Rodríquez MN
    Med Clin (Barc); 1991 Apr; 96(16):635-6. PubMed ID: 1646919
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia and cerebral venous thrombosis after low-molecular weight heparin.
    Shah SD; Shah C; Vora R
    Neurol India; 2010; 58(4):669-70. PubMed ID: 20739823
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombopenia during the treatment with nadroparine and furosemide].
    Labbe L; Devedeix N; Goyat-Labbe L; Seigneur M; Fialon P; Constans J; Conri C
    Therapie; 1993; 48(1):67-8. PubMed ID: 8395093
    [No Abstract]   [Full Text] [Related]  

  • 8. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
    Rota E; Bazzan M; Fantino G
    Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338
    [No Abstract]   [Full Text] [Related]  

  • 9. [Heparin-associated thrombocytopenia caused by low-molecular-weight heparin].
    Köninger J; Greinacher A; Müller-Beissenhirtz W; Strosche H
    Unfallchirurg; 1995 Jan; 98(1):49-51. PubMed ID: 7886465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin, low molecular weight heparin, and heparin-induced thrombocytopenia in the ICU.
    Warkentin TE; Cook DJ
    Crit Care Clin; 2005 Jul; 21(3):513-29. PubMed ID: 15992671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin.
    Pohl C; Kredteck A; Bastians B; Hanfland P; Klockgether T; Harbrecht U
    Neurology; 2005 Apr; 64(7):1285-7. PubMed ID: 15824368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heparin induced thrombocytopenia type II after the use of low-molecular weight heparin. Case report and review of the literature].
    Franke J; Schaeper O; Kayser R; Mahlfeld K
    Unfallchirurg; 2003 Jan; 106(1):77-81. PubMed ID: 12552397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of heparin-induced thrombocytopenia with fondaparinux.
    Harenberg J; Jörg I; Fenyvesi T
    Haematologica; 2004 Aug; 89(8):1017-8. PubMed ID: 15339691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombocytopenia with low molecular weight heparin with research of positive anti-blood platelets antibodies in front of Fraxiparin].
    Roland JG; Massade E; Serrano M; Touzain F; Franco A
    Therapie; 1991; 46(6):498. PubMed ID: 1668043
    [No Abstract]   [Full Text] [Related]  

  • 15. Bilateral adrenal hemorrhage associated with heparin induced thrombocytopenia.
    Kurtz LE; Yang S
    Am J Hematol; 2007 Jun; 82(6):493-4. PubMed ID: 17266058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thromboembolic disease and thrombocytopenia associated with the use of low-molecular weight heparins].
    Bóveda Treviño JL; Gràcia Gozalo RM; Barrabés J; Monasterio J
    Med Clin (Barc); 1991 May; 96(18):718-9. PubMed ID: 1649359
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis.
    Alsaleh KA; Al-Nasser SM; Bates SM; Patel A; Warkentin TE; Arnold DM
    Am J Hematol; 2008 Nov; 83(11):876-8. PubMed ID: 18803278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia with acute aortic and renal thrombosis in a patient treated with low-molecular-weight heparin.
    Chevalier J; Ducasse E; Dasnoy D; Puppinck P
    Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):209-12. PubMed ID: 15649731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute adrenal insufficiency due to bilateral adrenal hematoma following severe thrombopenia induced by low-molecular-weight heparin].
    Caubet O; Pillet O; Cherifi A; Mayet T; Castaing Y; Favarel Garrigues JC
    Presse Med; 1999 May 22-29; 28(19):1010-2. PubMed ID: 10379347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet aggregation tests in 26 cases of heparin-induced thrombopenia. Methodological, diagnostic problems and therapeutic aspects].
    Lecrubier C; Lecompte T; Potevin F; Horellou MH; Conard J; Samama M
    J Mal Vasc; 1987; 12 Suppl B():128-32. PubMed ID: 2834484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.